Core Points - The company, Hebang Biotechnology (603077.SH), announced the need to pay a total of 71.474 million yuan in corporate income tax and late fees for the period from January 1, 2023, to December 31, 2023 [1] - As of the date of the announcement, the company has completed the payment of the aforementioned tax and late fees, and this matter does not involve any administrative penalties [1] - The payment of the tax and late fees will be recorded in the company's 2025 financial results, with an expected impact of 71.474 million yuan on the net profit attributable to shareholders of the listed company for the year 2025, subject to the final audited financial statements for that year [1]

Group 1 - The company has approved a total guarantee limit of up to 63 billion for wholly-owned subsidiaries, 16.6 billion for controlling subsidiaries, and 1.05 billion for joint ventures, with additional guarantees for upstream and downstream enterprises and dealers totaling 53.9 billion and 173 billion respectively [3] - In July 2025, the company increased the guarantee limit for related parties to a total of 89.4 billion [3] - The company has provided guarantees to financial companies to support product sales and enhance supply chain competitiveness, considering factors such as profitability and debt repayment ability [6] Group 2 - From April to July 2025, the total external guarantees amounted to 31.10 billion, with a repurchase responsibility of 5 billion [7] - As of the end of July 2025, the outstanding external guarantees were 85.25 billion, with a repurchase responsibility of 40.13 billion [7] - The company has no overdue guarantees, and all guarantees are within the authorized limits of the annual shareholders' meeting [8] Group 3 - The company has conducted a self-inspection and found that it needs to pay back taxes and penalties amounting to 28.83 million, which will impact the 2025 net profit [10][11] - The tax payments have been completed, and there are no administrative penalties involved [10]